XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive (loss) income
Total
Beginning balance (in shares) at Dec. 31, 2022 168,324,995        
Beginning balance at Dec. 31, 2022 $ 17 $ 1,941,569 $ (1,453,744) $ 30,585 $ 518,427
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options (in shares) 7,816        
Exercise of stock options   15     15
Vesting of restricted stock awards and units (in shares) 3,927,390        
Vesting of performance-based stock units (in shares) 381,071        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (1,223,900)        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (3,912)     (3,912)
Stock-based compensation expense   16,914     16,914
Other comprehensive loss       (14,231) (14,231)
Net loss     (73,285)   (73,285)
Ending balance (in shares) at Sep. 30, 2023 171,417,372        
Ending balance at Sep. 30, 2023 $ 17 1,954,586 (1,527,029) 16,354 443,928
Beginning balance (in shares) at Jun. 30, 2023 170,958,400        
Beginning balance at Jun. 30, 2023 $ 17 1,950,079 (1,513,528) 17,679 454,247
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options (in shares) 6,899        
Exercise of stock options   13     13
Vesting of restricted stock awards and units (in shares) 612,818        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (160,745)        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (456)     (456)
Stock-based compensation expense   4,950     4,950
Other comprehensive loss       (1,325) (1,325)
Net loss     (13,501)   (13,501)
Ending balance (in shares) at Sep. 30, 2023 171,417,372        
Ending balance at Sep. 30, 2023 $ 17 1,954,586 (1,527,029) 16,354 $ 443,928
Beginning balance (in shares) at Dec. 31, 2023 172,083,667       172,083,667
Beginning balance at Dec. 31, 2023 $ 17 1,958,909 (1,519,950) 13,787 $ 452,763
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options (in shares) 8,677        
Exercise of stock options   17     17
Vesting of restricted stock awards and units (in shares) 3,444,670        
Vesting of performance-based stock units (in shares) 288,672        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (1,089,888)        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (3,035)     (3,035)
Stock-based compensation expense   12,061     12,061
Other comprehensive loss       (5,673) (5,673)
Net loss     (60,599)   $ (60,599)
Ending balance (in shares) at Sep. 30, 2024 174,735,798       174,735,798
Ending balance at Sep. 30, 2024 $ 17 1,967,952 (1,580,549) 8,114 $ 395,534
Beginning balance (in shares) at Jun. 30, 2024 174,437,242        
Beginning balance at Jun. 30, 2024 $ 17 1,964,304 (1,567,127) 7,828 405,022
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options (in shares) 53        
Vesting of restricted stock awards and units (in shares) 417,633        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (119,130)        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (397)     (397)
Stock-based compensation expense   4,045     4,045
Other comprehensive loss       286 286
Net loss     (13,422)   $ (13,422)
Ending balance (in shares) at Sep. 30, 2024 174,735,798       174,735,798
Ending balance at Sep. 30, 2024 $ 17 $ 1,967,952 $ (1,580,549) $ 8,114 $ 395,534